Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.
Borràs C, Canyelles M, Girona J, Ibarretxe D, Santos D, Revilla G, Llorente-Cortes V, Rotllan N, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Masana L, Arrieta F, Martínez-Botas J, Gómez-Coronado D, Ribalta J, Tondo M, Blanco-Vaca F, Escolà-Gil JC. Borràs C, et al. Among authors: revilla g. JACC Basic Transl Sci. 2024 Aug 28;9(10):1195-1210. doi: 10.1016/j.jacbts.2024.06.008. eCollection 2024 Oct. JACC Basic Transl Sci. 2024. PMID: 39534644 Free PMC article.
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport.
Hueso M, Griñán R, Mallen A, Navarro E, Purqueras E, Gomá M, Sbraga F, Blasco-Lucas A, Revilla G, Santos D, Canyelles M, Julve J, Escolà-Gil JC, Rotllan N. Hueso M, et al. Among authors: revilla g. Biomed Pharmacother. 2022 Feb;146:112596. doi: 10.1016/j.biopha.2021.112596. Epub 2021 Dec 28. Biomed Pharmacother. 2022. PMID: 35062066 Free article.
LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies.
Revilla G, Cedó L, Tondo M, Moral A, Pérez JI, Corcoy R, Lerma E, Fuste V, Reddy ST, Blanco-Vaca F, Mato E, Escolà-Gil JC. Revilla G, et al. Semin Cancer Biol. 2021 Aug;73:134-157. doi: 10.1016/j.semcancer.2020.11.012. Epub 2020 Nov 26. Semin Cancer Biol. 2021. PMID: 33249202 Review.
Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.
Revilla G, Pons MP, Baila-Rueda L, García-León A, Santos D, Cenarro A, Magalhaes M, Blanco RM, Moral A, Ignacio Pérez J, Sabé G, González C, Fuste V, Lerma E, Faria MDS, de Leiva A, Corcoy R, Carles Escolà-Gil J, Mato E. Revilla G, et al. Sci Rep. 2019 Jul 16;9(1):10260. doi: 10.1038/s41598-019-46727-2. Sci Rep. 2019. PMID: 31311983 Free PMC article.
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.
Revilla G, Al Qtaish N, Caruana P, Sainz-Ramos M, Lopez-Mendez T, Rodriguez F, Paez-Espinosa V, Li C, Vallverdú NF, Edwards M, Moral A, Pérez JI, Escolà-Gil JC, Pedraz JL, Gallego I, Corcoy R, Céspedes MV, Puras G, Mato E. Revilla G, et al. Biomolecules. 2023 Nov 13;13(11):1647. doi: 10.3390/biom13111647. Biomolecules. 2023. PMID: 38002329 Free PMC article.
36 results